These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice. Plata F; Gomard E; Leclerc JC; Levy JP J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862 [No Abstract] [Full Text] [Related]
25. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells]. Kharkevich DD; Suslov AP Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371 [No Abstract] [Full Text] [Related]
26. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro. Nelson RD; Leu RW J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355 [TBL] [Abstract][Full Text] [Related]
27. Suppression of the immune response in tumor-bearing mice. II. Characterization of adherent suppressor cells. Bluestone JA; Lopez C J Natl Cancer Inst; 1979 Nov; 63(5):1221-7. PubMed ID: 228106 [TBL] [Abstract][Full Text] [Related]
28. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors. Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589 [TBL] [Abstract][Full Text] [Related]
30. Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay. Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW J Immunol; 1978 Jun; 120(6):1981-5. PubMed ID: 659888 [TBL] [Abstract][Full Text] [Related]
31. [Genetic control of production of a lymphokine inhibiting macrophage migration in mice]. Petrov RV; Koval'chuk LV; Sokolova EV; Burtseva LV Genetika; 1980; 16(10):1825-33. PubMed ID: 7007159 [TBL] [Abstract][Full Text] [Related]
32. [Production of a macrophage migration suppression factor when T-cells react with mutant H-2 antigens in mixed lymphocyte cultures]. Kharkevich DD; Suslov AP; Blandova ZK Biull Eksp Biol Med; 1981 Feb; 91(2):191-3. PubMed ID: 7013849 [TBL] [Abstract][Full Text] [Related]
33. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells. Brunner KT; MacDonald HR; Cerottini JC J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076 [No Abstract] [Full Text] [Related]
34. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells. Lake JP; Kapp JA; Pierce CW J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108 [TBL] [Abstract][Full Text] [Related]
35. Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors. II. Requirement for T-cell subpopulations and macrophages. Sarlo KT; Mortensen RF Cell Immunol; 1983 Jul; 79(2):211-9. PubMed ID: 6307531 [TBL] [Abstract][Full Text] [Related]
36. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity. Maier T; Holda JH; Claman HN J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774 [TBL] [Abstract][Full Text] [Related]
37. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH; Daynes RA; Hodes RJ J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117 [TBL] [Abstract][Full Text] [Related]
38. [Nature of the cells regulating the production of a migration inhibition factor in C57BL/6 strain mice with low response to Candida albicans antigen]. Vorob'ev KV; Koval'chuk LV; Gankovskaia LV Biull Eksp Biol Med; 1984 Nov; 98(11):601-2. PubMed ID: 6239664 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays. Fossati G; Holden HT; Herberman RB Cancer Res; 1975 Sep; 35(9):2600-8. PubMed ID: 167966 [TBL] [Abstract][Full Text] [Related]
40. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice. Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]